ARCA BIOPHARMA INC (ABIOXXXX)
Institutional ownership reported to the SEC as of Q1 2019, across 2 quarters.
11
Reporting holders
$863.0K
Reported value
0.0%
Held as options
+1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $337.0K | 901,611 | 0.00% | 2q | +10.1%+$31.1K |
| Tekla Capital Management LLC | $303.0K | 811,227 | 0.01% | 2q | HELD |
| ACADIAN ASSET MANAGEMENT LLC | $82.0K | 219,236 | 0.00% | 2q | +42.8%+$24.6K |
| Aveo Capital Partners, LLC | $35.0K | 93,258 | 0.02% | 2q | HELD |
| CITADEL ADVISORS LLC | $31.0K | 81,938 | 0.00% | new | NEW |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $27.0K | 72,890 | 0.00% | new | NEW |
| VANGUARD GROUP INC | $19.0K | 50,481 | 0.00% | 2q | HELD |
| GEODE CAPITAL MANAGEMENT, LLC | $18.0K | 48,679 | 0.00% | 2q | -50.0%-$18.0K |
| NORTHERN TRUST CORP | $5.0K | 13,971 | 0.00% | 2q | -0.6% |
| TWO SIGMA SECURITIES, LLC | $5.0K | 12,428 | 0.00% | new | NEW |
| MORGAN STANLEY | $1.0K | 2,000 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2019 | 11 | $863.0K | 2,307,719 | 3 | 2 | 2 | 0.0% |
| Q4 2018 | 10 | $710.0K | 2,125,300 | 0 | 0 | 0 | 0.0% |